• 1
    Allander T., Tammi M.T., Eriksson M., Bjerkner A., Tiveljung-Lindell A., Andersson B. ( 2005) Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci USA 102: 128916.
  • 2
    Moriyama M., Hamada H., Okada M., Tsuchiya N., Maru H., Shirato Y., Maeda Y., Hirose Y., Yoshida M., Omura Y., Honda T., Muto A., Hayashi K., Terai M. ( 2010) Distinctive clinical features of human bocavirus in children younger than two years. Eur J Pediatr 169: 108792.
  • 3
    Lindner J., Zehentmeier S., Franssila R., Barabas S., Schroeder J., Deml L., Modrow S. ( 2008) CD4+ T helper cell responses against human bocavirus viral protein 2 viruslike particles in healthy adults. J Infect Dis 198: 167784.
  • 4
    Chung J.Y., Han T.H., Kim J.S., Kim S.W., Park C.G., Hwang E.S. ( 2008) Th1 and Th2 cytokine levels in nasopharyngeal aspirates from children with human bocavirus bronchiolitis. J Clin Virol 43: 2235.
  • 5
    Larrañaga C.L., Ampuero S.L., Luchsinger V.F., Carrión F.A., Aguilar N.V., Morales P.R., Palomino M.A., Tapia L.F., Avendaño L.F. ( 2009) Impaired immune response in severe human lower tract respiratory infection by respiratory syncytial virus. Pediatr Infect Dis J 28: 86773.
  • 6
    Patel J.A., Nair S., Grady J., Revai K., Victor S., Brasier A.R., Chonmaitree T. ( 2009) Systemic cytokine response profiles associated with respiratory virus-induced acute otitis media. Pediatr Infect Dis J 28: 40711.
  • 7
    Legg J.P., Hussain I.R., Warner J.A., Johnston S.L., Warner J.O. ( 2003) Type 1 and Type 2 cytokine imbalance in acute respiratory syncytial virus bronchitis. Am J Respir Crit Care Med 168: 6339.
  • 8
    Tripp R.A., Moore D., Barskey A. ( 2002) 4th, Jones L., Moscatiello C., Keyserling H., Anderson L. J. Peripheral blood mononuclear cells from infants hospitalized because of respiratory syncytial virus infection express T helper-1 and T helper-2 cytokines and CC chemokine messenger RNA. J Infect Dis 185: 138894.
  • 9
    Mason C.M., Dobard E., Summer W.R., Nelson S. ( 1997) Intraportal lipopolysaccharide suppresses pulmonary antibacterial defense mechanisms. J Infect Dis 176: 1293302.
  • 10
    Bauer T.T., Montón C., Torres A., Cabello H., Fillela X., Maldonado A., Nicolás J.M., Zavala E. ( 2000) Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls. Thorax 55: 4652 .
  • 11
    Yende S., Tuomanen E.I., Wunderink R., Kanaya A., Newman A.B., Harris T., Rekeneire N., Kritchevsky S.B. ( 2005) Preinfection systemic inflammatory markers and risk of hospitalization due to pneumonia. Am J Respir Crit Care Med 172: 14406.
  • 12
    Kato M., Tsukagoshi H., Yoshizumi M., Saitoh M., Kozawa K., Yamada Y., Maruyama K., Hayashi Y., Kimura H. ( 2011) Different cytokine profile and eosinophil activation are involved in rhinovirus- and RS virus-induced acute exacerbation of childhood wheezing. Pediatr Allergy Immunol 22: e8794.
  • 13
    Terai M., Honda T., Yamamoto S., Yoshida M., Tsuchiya N., Moriyama Y., Matsui T., Tokutake S., Suzuki E., Shirato Y., Muto A., Hayashi K., Hamada H. ( 2011) Early induction of interleukin-5 and peripheral eosinophilia in acute pneumonia in Japanese children infected by pandemic 2009 influenza A in the Tokyo area. Microbiol Immunol 55: 3416.
  • 14
    Gaffen S.L., Liu K.D. ( 2004) Overview of interleukin-2 function, production and clinical applications. Cytokine 28: 10923.
  • 15
    Okamoto M., Kato S., Oizumi K., Kinoshita M., Inoue Y., Hoshino K., Akira S., Mckenzie A.N.J., Young H.A., Hoshino T. ( 2002) Interleukin 18(IL-18) in synergy with IL-2 induces lethal lung injury in mice—potential role for cytokines, chemokines, and natural killer cells in the pathogenesis of interstitial pneumonia. Blood 99: 128998.
  • 16
    Tirado R., Ortega A., Sarmiento R.E., Gomez B. ( 2005) Interleukin-8 mRNA synthesis and protein secretion are continuously up-regulated by respiratory syncytial virus persistently infected cells. Cell Immunol 233: 617.